U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H12N2S.ClH
Molecular Weight 240.752
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEXAMISOLE HYDROCHLORIDE

SMILES

Cl.C1CN2C[C@H](N=C2S1)C3=CC=CC=C3

InChI

InChIKey=LAZPBGZRMVRFKY-PPHPATTJSA-N
InChI=1S/C11H12N2S.ClH/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10;/h1-5,10H,6-8H2;1H/t10-;/m0./s1

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C11H12N2S
Molecular Weight 204.291
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Dexamisole is the dextro-isomer of tetramisole, a broad spectrum anthelmintic. Dexamisole significantly improves mood and psychotonicity. In adrenergically innervated blood vessels dexamisole inhibits neuronal uptake of norepinephrine more than levamisole. Dexamisole antagonized the reserpine-induced hypothermia but was ineffective in the apomorphine-induced hypothermia in mice. It reduced ptosis produced by reserpine in mice but this effect was very weak. The effect of dexamisole on the amphetamine-induced hyperactivity depended upon the animal species. Dexamisole reduced the duration of immobility in the despair test in rats. It did not modify the 5-HTP-induced head twitch reaction in mice but produced stimulation of the hind limb flexor reflex in spinal rats. The latter effect was blocked by phenoxybenzamine but not by cyproheptadine and metergoline. Dexamisole also exerted a sedative and hypothermic effect. The above findings indicate that the pharmacological profile of dexamisole resembles in some respects that of tricyclic antidepressants; they also point out that this drug has a central noradrenergic activity.

Approval Year

PubMed

PubMed

TitleDatePubMed
Psychopharmacological profile of dexamisole.
1980-01-01

Sample Use Guides

In Vivo Use Guide
Sources: DOI: 10.1177/030006057400200214
Dosage: 50 mg three times a day
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:40:08 GMT 2025
Edited
by admin
on Mon Mar 31 21:40:08 GMT 2025
Record UNII
84VUY5WNF2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEXAMISOLE HYDROCHLORIDE
Common Name English
R-12,563
Preferred Name English
IMIDAZO(2,1-B)THIAZOLE, 2,3,5,6-TETRAHYDRO-6-PHENYL-, HYDROCHLORIDE (1:1), (6R)-
Systematic Name English
IMIDAZO(2,1-B)THIAZOLE, 2,3,5,6-TETRAHYDRO-6-PHENYL-, MONOHYDROCHLORIDE, (R)-
Systematic Name English
TETRAMISOLE HYDROCHLORIDE, (R)-
Common Name English
D-TETRAMISOLE HYDROCHLORIDE
Common Name English
DEXAMISOLE HCL
Common Name English
R-12563
Code English
IMIDAZO(2,1-B)THIAZOLE, 2,3,5,6-TETRAHYDRO-6-PHENYL-, MONOHYDROCHLORIDE, (R)-(+)-
Systematic Name English
IMIDAZO(2,1-B)THIAZOLE, 2,3,5,6-TETRAHYDRO-6-PHENYL-, MONOHYDROCHLORIDE, (6R)-
Systematic Name English
Code System Code Type Description
CAS
16595-76-9
Created by admin on Mon Mar 31 21:40:08 GMT 2025 , Edited by admin on Mon Mar 31 21:40:08 GMT 2025
PRIMARY
ECHA (EC/EINECS)
240-653-0
Created by admin on Mon Mar 31 21:40:08 GMT 2025 , Edited by admin on Mon Mar 31 21:40:08 GMT 2025
PRIMARY
EPA CompTox
DTXSID20168050
Created by admin on Mon Mar 31 21:40:08 GMT 2025 , Edited by admin on Mon Mar 31 21:40:08 GMT 2025
PRIMARY
PUBCHEM
197152
Created by admin on Mon Mar 31 21:40:08 GMT 2025 , Edited by admin on Mon Mar 31 21:40:08 GMT 2025
PRIMARY
FDA UNII
84VUY5WNF2
Created by admin on Mon Mar 31 21:40:08 GMT 2025 , Edited by admin on Mon Mar 31 21:40:08 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY